Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.
Twitter handle: @jeffmason1
LONDON/SHANGHAI Investors are betting on China's potential to feed the global pharmaceutical pipeline, putting a multi-billion-dollar price tag on a handful of stocks, even as the country struggles to close a huge R&D gap with the West.
LONDON Drugmakers and medical devices companies are drawing up plans to protect supply chains in case Britain crashes out of the European Union without a trade deal, and some small service businesses are already relocating to stay inside the bloc.
Pfizer said on Tuesday it was considering the sale or spin-off of its consumer healthcare business, shaking up the industry and potentially putting a headache pill to lip balm operation worth some $15 billion up for grabs.
LONDON Europe's drugs regulator has issued a 31.8 million-pound ($42 million) tender for temporary workers and warned it could face a major budget hit as it struggles with the fallout of Brexit, which will uproot it from London.
LONDON Britain's pharmaceuticals industry has thrown in the towel in a legal battle over new cost curbs imposed by the state-run health service, after failing to secure a judicial review.
LONDON Roche's immunotherapy drug Tecentriq has lost market share to Merck & Co's rival Keytruda since a clinical trial showed the Swiss company's medicine failed to improve overall survival in bladder cancer.
STOCKHOLM/LONDON A trio of Swiss, American and British scientists won the 2017 Nobel chemistry prize on Wednesday for developing cryo-electron microscopy, allowing researchers to see biological molecules frozen in action. | Video
LONDON, Oct 4 Britain's pharmaceuticals industry failed to secure a judicial review of new cost curbs, which mean drugs costing NHS England more than 20 million pounds ($26 mln) annually no longer get automatic funding.
STOCKHOLM/LONDON Three U.S. scientists won the 2017 Nobel prize for physics on Tuesday for opening up a new era of astronomy by detecting gravitational waves, ripples in space and time foreseen by Albert Einstein a century ago. | Video
LONDON Access to new medicines and safety checks on existing treatments will be jeopardized if politicians pick a new home for Europe's London-based drugs regulator that is unacceptable to staff, its executive director told Reuters.